WUHAN GENERAL GROUP (CHINA), INC. Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Wuhan General Group (China), Inc.
401 Ryland St. Ste 200-A, Reno, NV 89502
_______________________________
+27 (82) 413 5457
https://m2bio.co/
willem@m2bio.co
SIC - 2833 - Medicinal and botanicals
Annual Report
For the Period Ending: 31 December 2021
As of 31 December 2021, the number of shares outstanding of our Common Stock was: 54,849,662
As of 30 September 2021, the number of shares outstanding of our Common Stock was: 50,999,662
As of 31 December 2020, the number of shares outstanding of our Common Stock was: 51,605,160
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes:
No:
Yes:
No:Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:Yes:
No:
1
efined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) orsecurities;
(iii) A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
(iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
03/2007 Wuhan General Group (China) Inc formely United National Film Corp.
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years;
09/12/2006 Nevada Active
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
NONE
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
NONE
:
Unit 01, Mason's Press, 7 Ravenscraig Road, Woodstock, 7925, Cape Town, South Africa
e of business:
Check box if principal executive office and principal place of business are the same address:
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes:
No:If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
N/A
Security Information
Trading symbol:
Exact title and class of securities outstanding: CUSIP:
Par or stated value:
WUHN Common 982569105 0.0001
as of date: December 31, 2021 | ||
as of date: December 31, 2021 | ||
as of date: December 31, 2021 | ||
as of date: December 31, 2021 | ||
Exact title and class of securities outstanding: | Preferred | |
Par or stated value: | 0.0001 | |
Total shares authorized: | 50,000,000 | as of date: December 31, 2021 |
Total shares outstanding: | 15,000,000 | as of date: December 31, 2021 |
Exact title and class of securities outstanding: | Warrants A | |
Par or stated value: | 0.0001 | |
Total shares authorized: | 3,000,000 | as of date: December 31, 2021 |
Total shares outstanding: | 2,250,000 | as of date: December 31, 2021 |
Exact title and class of securities outstanding: | Warrants B | |
Par or stated value: | 0.0001 | |
Total shares authorized: | 3,000,000 | as of date: December 31, 2021 |
Total shares outstanding: | 1,390,000 | as of date: December 31, 2021 |
Exact title and class of securities outstanding: | Warrants C | |
Par or stated value: | 0.0001 | |
Total shares authorized: | 3,000,000 | as of date: December 31, 2021 |
Total shares outstanding: | 1,390,000 | as of date: December 31, 2021 |
Exact title and class of securities outstanding: | Options A | |
Par or stated value: | 0.0001 | |
Total shares authorized: | 3,000,000 | as of date: December 31, 2021 |
Total shares outstanding: | 1,000,000 | as of date: December 31, 2021 |
Transfer Agent |
Total shares authorized: 150,000,000
Total shares outstanding: 54,849,662
Number of shares in the Public Float2: 16,333,204
Total number of shareholders of record:
171
All additional class(es) of publicly traded securities (if any):
Name: | EQ Shareowner Services |
Phone: | 303-282-4800 |
Email: | Michaelie.Wingo@equiniti.com |
Address: | 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120 |
2l number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficialte family members of officers, directors and control persons.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)
Page 3 of 31
Is the Transfer Agent registered under the Exchange Act?3 Yes:No:
3) Issuance History
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstandingin the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods:
Shares Outstanding as of Second Most Recent Fiscal Year End: Opening Balance Date 01/01/2020 Common: 43,271,310 Preferred: 15,000,000 Warrant Series A: 0 Warrant Series B: 0 Warrant Seriece C: 0 Option Series A: 0 | *Right- | ||||||||
Date of Transaction | Transaction type (e.g. new issuance, cancellation, shares returned to treasury) | Number of Shares Issued (or cancelled) | Class of Securities | Value of shares issued ($/per share) at Issuance | Were the shares issued at a discount to market price at the time of issuance? (Yes/No) | Individual/ Entity Shares were issued to (entities must have individual with voting / investment control disclosed). | Reason for share issuance (e.g. for cash or debt conversion) -OR-Nature of Services Provided | Restricted or Unrestricted as of this filing. | Exemption or Registration Type. |
02/26/2020 | New issuance | 4,283,850 | common | .004 | yes | Slingshot Marketing Solutions, LLC (Benjamin Barry) | debt conversion | Unrestricted | Exemption |
05/05/2020 | New issuance | 500,000 | common | .03 | no | StockVest (Art Brent) | Consulting services | Restricted | Exemption |
05/21/2020 | New issuance | 50,000 | common | .03 | no | William Selah Abrams | Consulting services | Restricted | Exemption |
09/29/2020 | New issuance | 100,000 | common | .10 | yes | Ronald Hargrove | Private Placement | Restricted | Exemption |
3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
09/29/2020 | New issuance | 50,000 | common | .10 | yes | Robert Thomas Hooper | Private Placement | Restricted | Exemption |
09/30/2020 | New issuance | 150,000 | common | .10 | yes | Clark Winkler | Private Placement | Restricted | Exemption |
10/01/2020 | New issuance | 75,000 | common | .10 | yes | Allen Robert Tripp | Private Placement | Restricted | Exemption |
10/01/2020 | New issuance | 125,000 | common | .10 | yes | Clyde L Blanchi | Private Placement | Restricted | Exemption |
10/01/2020 | New issuance | 200,000 | common | .10 | yes | John Walters | Private Placement | Restricted | Exemption |
10/02/2020 | New issuance | 100,000 | common | .10 | yes | Philip J Munschauer | Private Placement | Restricted | Exemption |
10/07/2020 | New issuance | 50,000 | common | .10 | yes | Ted Vruggink | Private Placement | Restricted | Exemption |
10/08/2020 | New issuance | 150,000 | common | .10 | yes | Timothy Jay Nagelkirk | Private Placement | Restricted | Exemption |
10/08/2020 | New issuance | 50,000 | common | .10 | yes | Taylor Blom | Private Placement | Restricted | Exemption |
10/15/2020 | New issuance | 75,000 | common | .10 | yes | Michael David Ware | Private Placement | Restricted | Exemption |
12/09/2020 | New issuance | 350,000 | common | .10 | yes | Jeffrey J Krueger | Private Placement | Restricted | Exemption |
12/10/2020 | New issuance | 250,000 | common | .10 | yes | Brian Corday | Private Placement | Restricted | Exemption |
12/27/2020 | New issuance | 150,000 | common | .10 | yes | John Wolters | Private Placement | Restricted | Exemption |
12/27/2020 | New issuance | 125,000 | common | .10 | yes | Ronald Hargrove | Private Placement | Restricted | Exemption |
12/29/2020 | New issuance | 1,500,000 | common | .30 | yes | ThreeD Capital ( Sheldon Inwentash) | Private Placement | Restricted | Exemption |
01/01/2021 | New issuance | 1,500,000 | warrant series A | .30 | yes | ThreeD Capital ( Sheldon Inwentash) | Private Placement | Restricted | Exemption |
01/01/2021 | New issuance | 750,000 | warrant series A | .20 | yes | ThreeD Capital ( Sheldon Inwentash) | Consulting services | Restricted | Exemption |
01/01/2021 | New issuance | 750,000 | common | .20 | yes | ThreeD Capital ( Sheldon Inwentash) | Consulting services | Restricted | Exemption |
01/01/2021 | New issuance | 1,000,000 | option | .35 | yes | Park Place Limited ( Sheldon Inwentash) | Consulting services | Restricted | Exemption |
02/12/2021 | New issuance | 2,000,000 | common | par value | yes | ZCMA Holdings Limited(Mitch | Management Compensation | Restricted | Exemption |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Wuhan General Group (China) Inc. published this content on 30 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2022 13:52:08 UTC.
